Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Semi-automated clinical chemistry analyzers • Fully automated clinical chemistry analyzers PART 07: Market segmentation by end-users • Hospitals and clinics • Diagnostic centers PART 08: Geographical segmentation • Clinical chemistry analyzers market in Americas • Clinical chemistry analyzers market in EMEA • Clinical chemistry analyzers market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 11: Market trends • Focus on fully automated clinical chemistry analyzers • Outsourcing from hospitals to reference laboratories • Higher adoption rate of POCT PART 12: Vendor landscape • Competitive landscape analysis PART 13: Key vendor analysis • Abbott Laboratories • F. Hoffmann-La Roche • Thermo Fisher Scientific • Key company to watch • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits  Exhibit 01: Classification of immunochemistry Exhibit 02: Overview: Global clinical chemistry analyzers market 2016-2021 Exhibit 03: Major applications areas for clinical chemistry analyzers Exhibit 04: Common clinical chemistry tests Exhibit 05: Global clinical chemistry analyzers market 2016-2021 ($ billions) Exhibit 06: Five forces analysis Exhibit 07: Global clinical chemistry analyzers market by product type 2016 Exhibit 08: Semi-automated clinical chemistry analyzers market 2016-2021: Market overview Exhibit 09: Key product offerings: Semi-automated clinical chemistry analyzers Exhibit 10: Semi-automated clinical chemistry analyzers market 2016-2021 ($ billions) Exhibit 11: Fully automated clinical chemistry analyzers market 2016-2021: Market overview Exhibit 12: Key product offerings: Fully automated clinical chemistry analyzers Exhibit 13: Fully automated clinical chemistry analyzers market 2016-2021 ($ billions) Exhibit 14: Global clinical chemistry analyzers market segmentation by end-users 2016 Exhibit 15: Global clinical chemistry analyzers market by end-users: Impact analysis Exhibit 16: Global clinical chemistry analyzers market segmentation by geography 2016 Exhibit 17: Clinical chemistry analyzers market in Americas 2016-2021: Market overview Exhibit 18: Clinical chemistry analyzers market in Americas 2016-2021 ($ billions) Exhibit 19: Market attractiveness of clinical chemistry analyzers in Americas Exhibit 20: Clinical chemistry analyzers market in EMEA 2016-2021: Market overview Exhibit 21: Clinical chemistry analyzers market in EMEA 2016-2021 ($ billions) Exhibit 22: Market attractiveness of clinical chemistry analyzers in EMEA Exhibit 23: Clinical chemistry analyzers market in APAC 2016-2021: Market overview Exhibit 24: Clinical chemistry analyzers market in APAC 2016-2021 ($ billions) Exhibit 25: Market attractiveness of clinical chemistry analyzers in APAC Exhibit 26: Benefits of leasing instruments Exhibit 27: Impact of drivers Exhibit 28: Impact of challenges Exhibit 29: Competitive structure analysis of global clinical chemistry analyzers market 2016 Exhibit 30: Competitive landscape analysis of global clinical chemistry analyzers market 2016 Exhibit 31: Strategic success factors of companies in global clinical chemistry analyzers market Exhibit 32: Abbott Laboratories: Key highlights Exhibit 33: Abbott Laboratories: Strength assessment Exhibit 34: Abbott Laboratories: Strategy assessment Exhibit 35: Abbott Laboratories opportunity assessment Exhibit 36: F. Hoffmann-La Roche: Key highlights Exhibit 37: F. Hoffmann-La Roche: Strength assessment Exhibit 38: F. Hoffmann-La Roche: Strategy assessment Exhibit 39: F. Hoffmann-La Roche: Opportunity assessment Exhibit 40: Thermo Fisher Scientific: Key highlights Exhibit 41: Thermo Fisher Scientific: Strategy assessment Exhibit 42: Thermo Fisher Scientific: Strategy assessment Exhibit 43: Thermo Fisher Scientific: Opportunity assessment Exhibit 44: Danaher: Market assessment

Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Danaher, Analytik Jena, BioSystems Diagnostics, DiaSys Diagnostic Systems, Diatron, EKF Diagnostics, ELITechGroup, HORIBA, Randox Laboratories, SFRI, and Shenzhen Mindray Bio-Medical Electronics.